Page 161 - ESHRE2019

10:45 O-238
A systematic review and meta-analysis comparing Biosimilar versus Originator Recombinant Follitropin Alfa in women undergoing IVF/ICSI
S. Longobardi1, B. Mol2, S.J. Chua3, R. Wang3, C. Venetis4, R. Papsch1, G. Trew5, R. Orvieto6, T. D’Hooghe1 1Merck KGaA, Global Medical Affairs Fertility, Darmstadt, Germany
2Monash University, Department of Obstetrics and Gynaecology, Clayton, Australia
3University of Adelaide, Robinson Research Institute and Adelaide Medical School, Adelaide, Australia 4UNSW Australia, Centre for Big Data Research in Health, Sydney, Australia
5The Fertility Partnership, Reproductive Medicine and Surgery, London, United Kingdom 6Sheba Academic Medical Centre, Department of Obstetrics and Gynecology, Ramat Gan, Italy
Follicular steroidogenesis in GnRH antagonist ovarian stimulation cycles with r-FSH vs. hp-HMG. A randomized controlled trial
E. Bosch Aparicio1, P. Alamá1, J.L. Romero1, M. Mari1, E. Labarta1 1IVI-RMA, Human Reproduction, Valencia, Spain
The dydrogesterone and FSH protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation in IVF/ICSI cycle
A.S. Gurbuz1, F. Gode2
1Novafertil IVF Center, Obstetrics and Gynecology, Konya, Turkey 2Bahcesehir University, Obstetrics and Gynecology, Istanbul, Turkey
Luteinizing hormone receptor deficiency in granulosa cells explains the retrieval of immature (germinal vesicle) oocytes after controlled ovarian stimulation
M. Casalechi1, M.T. Pereira1, I.K. Cavallo1, C. Dela Cruz1, F. Marcos dos Reis1
1Hospital das Clinicas da Universidade Federal de Minas Gerais, Dept. of Obstetrics and Gynecology, Belo Horizonte, Brazil
11:00 O-239
11:15 O-240
11:30 O-241
SCIENTIFIC PROGRAMME, WEDNESDAY, 26 JUNE I VIENNA, AUSTRIA – 23 TO 26 JUNE 2019 161
SCIENTIFIC PROGRAMME WEDNESDAY, 26 JUNE